Navigation Links
Douglas Harrington, MD Speaks at American Academy of Physicians Assistants 2013 Conference in Washington, DC
Date:5/29/2013

IRVINE, Calif., May 29, 2013 /PRNewswire/ -- Aviir, Inc. attended the AAPA's Impact 2013 conference in Washington DC, as guests of GUARDaHEART, a non-profit foundation focused on Heart Disease awareness, at the Walter E. Washington Convention Center on May 28-29. Aviir's Chief Executive Officer Douglas Harrington , MD, presented on May 28, in the Product Theatre.

(Logo:  http://photos.prnewswire.com/prnh/20130319/LA79677LOGO)

"The presentation, 'Preventing Heart Disease: Identifying the Vulnerable Patient Before it is Too Late' discussed the clinical dilemma of at-risk patients being missed by current standard risk assessments, such as lipid panels and the Framingham ten year risk projection," said Dr. Harrington. "Fifty percent of heart attack patients have normal cholesterol levels, making early detection imperative to reducing risk before a cardiac event occurs and in halting disease progression early enough for the patient to improve their health."

During his presentation, Dr. Harrington also spoke about Aviir's MIRISK™ and MIRISK VP™ cardiac risk assessments. The MIRISK VP provides a net reclassification index improvement of 43 percent over Framingham, the current gold standard 10-year risk assessment, and was demonstrated in the MESA population. The test has applications across many medical specialties due to the prevalence of heart disease (750,000 new cases a year in the U.S. alone.).

Aviir has partnered with GUARDaHEART to promote Heart Disease awareness and prevention. Together, they have organized education events and fundraisers, and helped to make patient lifestyle modification a welcoming experience. GUARDaHEART's recommendations, activities, and events provide meaningful support and motivation to anyone interested in improving their heart health.'/>"/>

SOURCE Aviir, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Hagens Berman Sobol Shapiro LLP and Douglas & London P.C. Announce Proposed Class Action Settlement in Bayer Combination Aspirin Products Litigation
2. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
3. Natalie Douglas, CEO von Idis, tritt Vorstand von Global Genes
4. RARE Project bei
5. Natalie Douglas, CEO of Idis, Joins Global Genes
6. RARE Project Board of Directors
7. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
8. World Renowned Scientist, Dr. Rongxiang Xu Speaks Out About Nobel Assembly Statement Claiming They Have Not Heard Of Him
9. American Academy of Family Physicians Foundation Launches Cities for Life
10. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
11. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" ... company, is delighted to announce its financial results ... which includes revenue for three months of $2,180,276 ... from advanced wound care product sales for the ... 24% to $1,742,672 compared to $1,400,065 for the ...
(Date:5/29/2015)... 2015  Epic Sciences announced today that the company ... castrate resistant prostate cancer patients, at the 2015 ... Oncology. This application expands the investigational utility of ... platform to characterize circulating tumor cell (CTC) genomic ... have heterogeneous clonal CTC populations harboring separate genetic ...
(Date:5/29/2015)... , May 29, 2015  World-renowned prostate surgeon and New ... on the benefit of MR/Ultrasound Fusion-Guided Biopsy for ... Prostate Cancer Center at Lenox Hill Hospital is ... System in New York City . We,ve ... risk prostate cancers. The use of an MRI makes for ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3MR/Ultrasound Fusion-Guided Biopsy Better Able to Detect Aggressive Prostate Cancer, New Study Says 2
(Date:5/29/2015)... North Carolina (PRWEB) May 29, 2015 ... confirmed that the newest Red Hot & Blue restaurant at ... business on Thursday, May 7, 2015. “The Red Hot & ... center for 18 years, but we have moved to a ... are now in the middle of all the activities on ...
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... May 29, 2015 World Patent Marketing, ... announces that it has signed a 10 year licensing ... that aims to let people learn about any topic ... time. , "This is an exciting day for World ... Scott J. Cooper, CEO and Creative Director of World ...
(Date:5/29/2015)... May 29, 2015 The print component ... a circulation of approximately 250,000 and an estimated readership ... a vast social media strategy, and across a network ... the digital version of the campaign, click here. ... print publication. Inside, the actress, model and producer details ...
(Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2
... Regions, These Markets Remain Stable, According to New ... HealthLeaders-InterStudy, a leading provider of managed care ... many regions of the country have halted because ... in Buffalo, N.Y., and Baton Rouge, La., are ...
... Calif., Jan. 26 Doctors at the,Northwoods Cancer ... patients,using new RapidArc radiotherapy technology from Varian Medical ... a retired machinist fighting prostate cancer, is,among the ... speed and accuracy of,RapidArc, which delivers image-guided intensity-modulated ...
... Jan. 26 ChromaDex Corporation, (OTC Bulletin Board: ... contract research, announced today that Nutrition Business Journal, ... care magazine, selected the Company as one of ... its achievement in setting stevia standards as part ...
... will add new technology to help ORBIS train doctors ... ORBIS International , a nonprofit ... donated PASCAL photocoagulator as part of a new partnership ... to treat a variety of retinal diseases, PASCAL dramatically ...
... Jan. 26 FluoroPharma Inc., a company ... Positron Emission Tomography (PET) market, announced today ... Office issued U.S. Patent No. 7,438,891, covering ... F18 labeled 2-fluorodeoxy-D-glucose (FDG). This patent, exclusively ...
... N.J., Jan. 26 Quest Diagnostics Incorporated (NYSE: ... of diagnostic testing, information and services, announced that ... in share repurchases. The company had approximately 190 ... 2008."This repurchase program demonstrates confidence in our performance ...
Cached Medicine News:Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 2Health News:Hospital Expansions in Buffalo, N.Y., and Baton Rouge, La., Contribute to Recession Resilience 3Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 2Health News:A Fast, New Cancer Fighting Tool Is Now Available in the Houston Area: RapidArc(TM) Radiotherapy Technology from Varian Medical Systems 3Health News:ChromaDex Awarded Nutrition Business Journal Scientific Achievement 2Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 2Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 3Health News:ORBIS International Receives Donated PASCAL(R) Photocoagulator From OptiMedica 4Health News:FluoroPharma Obtains US Patent for Imaging Cardiovascular Plaque using FDG 2Health News:Quest Diagnostics' Board Authorizes $500 Million in Share Repurchases 2
... 3Z slit lamp is designed to for ... ready slit lamp offers the popular horizontal ... to the ReSeeVit family of slit lamps ... market to capture clear, crisp digital images ...
... system combines continuous access, random ... a broad testing menu. AxSYM ... clinical laboratories to process a ... as well as adding tests ...
... an automated, multiparametric immunoassay system. ... stores the calibration in the ... cost-per-patient result. Plus, ease ... labor cost is also optimized. ...
... AIA-1800 is the newest and most advanced ... The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
Medicine Products: